In a report released today, Drew Babin from Robert W. Baird reiterated a Buy rating on Physicians Realty Trust (NYSE: DOC), with a price target of $18. The company’s shares opened today at $16.90.
According to TipRanks.com, Babin is a 4-star analyst with an average return of 9.6% and a 79.0% success rate. Babin covers the Financial sector, focusing on stocks such as Bluerock Residential Growth, Education Realty Trust, and Camden Property Trust.
Currently, the analyst consensus on Physicians Realty Trust is a Strong Buy with an average price target of $17.57, which is a 4.0% upside from current levels. In a report issued on August 2, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $18 price target.
.
See today’s analyst top recommended stocks >>
Based on Physicians Realty Trust’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $11.59 million. In comparison, last year the company had a net profit of $9.86 million.
Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of DOC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Physicians Realty Trust operates as a real estate investment trust, which leases and manages healthcare properties. It is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties which are leased to physicians, hospitals, and healthcare delivery systems.
